Apellis Pharmaceuticals has responded to “positive” 24-month data for its pioneering geographic atrophy (GA) therapy published in The Lancet, demonstrating...
Read moreRANZCO has rounded off a jam-packed annual congress in Perth, by welcoming almost 1,500 in-person delegates while welcoming 46 new...
Read moreIndependent optometry network Eyecare Plus has reinforced its digital presence with investments into various forms of digital advertising and marketing....
Read moreGeorge & Matilda (G&M) Eyecare has expanded its network in more than 100 communities with Joyce Optometrists, in the...
Read moreThe call has gone out for a medical professional to fill a vacancy on a committee that advises the Optometry...
Read moreNew eyewear brand Project Green is immediately living up to its sustainability ethos with more than 1,200 trees planted in...
Read moreThe Australian College of Optometry (ACO), and the Victorian Aboriginal Health Service (VAHS) are celebrating 25 years of dedicated optometry...
Read moreAn investigation into rare events of retinal vasculitis linked to Apellis Pharmaceutical’s new therapy, SYFOVRE, for geographic atrophy (GA) has...
Read moreWestern Australian ophthalmologist Professor David Mackey has been awarded the 2023 Glaucoma Australia (GA) ‘Quinlivan’ Research Grant. He will use...
Read morePeak bodies within the Australian eye health sector are drawing attention to two new reports on World Sight Day (12...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited